AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

LFMD · NASDAQ · Medical - Healthcare Information Services

LifeMD

Connecting patients to virtual primary and specialty care with pharmacy access.

$3.20

After-hours close+0.05 (+1.74%)

At close$3.15(−3.53%)

Something off on this page? Send us feedback.

Profile

LifeMD, Inc.LFMDHealth Care

Combines subscription-led virtual primary and specialty care with affiliated providers and pharmacy access for patients across the United States.

Provides direct-to-patient virtual care across primary and specialty needs, including urgent and chronic care, men’s and women’s health, hormone health, weight management, insomnia, dermatology, and cardiology. Clinically appropriate prescription and over-the-counter treatments sit alongside telemedicine, laboratory, and pharmacy access.

Built on a subscription-led model, the platform connects patients with affiliated clinical providers and pharmacy services throughout the United States. The women’s-health expansion came through the OHHMD asset acquisition, while the WorkSimpli sale left virtual care and pharmacy as the continuing business. Delivery depends on the digital-care platform, affiliated providers, pharmacy capability, laboratory access, and a US patient-care center.

Company facts

CEOJustin Schreiber

ListedJan 29, 2008

ExchangeNASDAQ

HeadquartersNew York, NY

CountryUnited States

Employees389

CIK0000948320

ISINUS53216B1044

Key statistics

Market cap$151.9M

EPS (ttm)−$0.5079

P/E (ttm)−6.18

ROE-179.1%

P/B18.84

P/S0.7426

Dividend yield—

Beta2.09vs XLV 0.19

Year to date −9.9% · Average volume (30d) 932.9K

Analysts

Price target, next 12 months$8.00+154.8%Median of 10 analysts · vs the Aug 28 close

ConsensusBuy10 of 10 analysts rate it buy or better

Ratings

Strong buyBuyHoldSellStrong sell

Target range

Last close $3.14

High$10.00+218.5%

Median$8.00+154.8%

Low$5.00+59.2%

12 months agoNowIn 12 months

Latest analyst notes

Date	Firm	Action	Rating	Prior target	Target
Aug 7, 2026	KeyBanc	Reiterate	Overweight	$8	$5
Aug 6, 2026	Lake Street	Target		$18	$5
Aug 6, 2026	Mizuho Securities	Target		$6	$7
Aug 6, 2026	BTIG	Reiterate	Buy	$10	$9
May 27, 2026	H.C. Wainwright	Target		$14	$10

Earnings

EPS

Estimate−$0.16

ReportedDue Nov 11, 2026

Revenue

Estimate$48.8M

ReportedDue Nov 11, 2026

History

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise	Next session
Aug 5, 2026Q2 FY26	−$0.15	−$0.16	−9.8%	$49.2M	$47.3M	−3.8%	−7.61%
May 6, 2026Q1 FY26	−$0.14	−$0.20	−42.9%	$48.8M	$50.2M	+2.7%	−14.80%
Mar 9, 2026Q4 FY25	−$0.01	−$0.04	−300.0%	$45.8M	$46.9M	+2.3%	+25.32%
Nov 17, 2025Q3 FY25	−$0.06	−$0.10	−66.7%	$48.6M	$60.2M	+23.9%	−13.53%

View details

Financial highlights

	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26
Revenue	$65.7M	$62.2M	$60.2M	$46.9M	$50.2M	$47.3M
Gross profit	$57.1M	$54.8M	$52.8M	$38.3M	$42.6M	$42.0M
Operating income	$2.5M	−$906.8K	−$2.0M	−$1.1M	−$8.9M	−$7.1M
Net income	$1.4M	−$2.1M	−$3.8M	−$1.5M	−$8.9M	−$7.1M
Diluted EPS	$0.01	−$0.06	−$0.10	−$0.05	−$0.20	−$0.16
Gross margin	86.8%	88.1%	87.7%	81.8%	84.8%	88.8%
Operating margin	3.9%	-1.5%	-3.3%	-2.3%	-17.8%	-15.1%

Fiscal years (4-quarter sums)FY21 $92.9M · FY22 $119.0M · FY23 $152.5M · FY24 $212.3M · FY25 $235.0M

Revenue by product · Q2 FY26

Product And Services$5.1M · 100%

Balance sheet, Jun 30, 2026Cash & short-term investments $25.1M · Total debt $6.0M · Total assets $59.9M · Shareholders' equity $8.0M

Dividends

No dividends on record.

Ownership

Institutions 44.96%21.74M sharesInsiders 14.57%7.05M sharesOther 40.47%19.57M shares

Shares outstanding 48.36M · Float 40.08M · 82.9% free float

Top shareholders13F · 13D/G · Form 4

Holder	Shares	% outstanding	Form	Filed
BlackRock, Inc.	3.03M	6.27%	13F	Aug 7, 2026
Federated Hermes, Inc.	2.75M	5.68%	13G	Jul 8, 2026
Justin Schreiber · director, officer: Chairman and CEO	2.68M	5.53%	Form 4	Aug 5, 2025
Vanguard Capital Management LLC	1.73M	3.59%	13F	Aug 13, 2026
State Street Corp	1.32M	2.73%	13F	Aug 7, 2026

Insider tradesForm 4

Date	Insider	Role	Shares	Avg price
Dec 9, 2025	Jessica Friedeman	officer: Chief Marketing Officer	−15,000	$3.61
Sep 10, 2025	Nicholas P. Alvarez	officer: Chief Acquisition Officer	−75,000	$5.92